Production of the primary vaccine candidate Plasmodium falciparum circumsporozoite protein (PfCSP) has proven difficult. This publication for the first time presents a method to produce a soluble, full-length PfCSP which could expedite malaria vaccine development. Read more here.

Dr. Sheshachalam has joined the team as a Scientist. He is an experienced cell biologist with a broad expertise in immunology, molecular biology and drug discovery. He obtained his PhD at the University of Alberta, Canada and previously worked in a drug company in India before joining us at TropIQ.

Dutch national radio (BNR) has conducted an interview with TropIQ’s CEO Koen Dechering on the recently published novel malaria drug candidate (see publication here). Listen to the interview here (in dutch).

A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end. The candidate drug offers considerable potential for combating this infectious disease. Full press release here en…

Mrs. De Bruijn is joining the Team as a Assistant Scientist with a wealth of experience in laboratory techniques in the fields of immunology, cell biology and molecular biology. She also gained experiences in immune-assays as well as test optimisation and validation during her previous work at QM diagnostics.

Mrs. Bijsterveld is joining TropIQ as a Business Administrator with a strong background in financial management in various different fields of work. In her previous affiliations she acquired higher lever understandings of implementation, transition and training.

TropIQ organised a science workshop at the IMC Weekend School. This is a supplementary school on Sundays for children (aged 10-14) from underprivileged neighbourhoods. Through a three-year course, professionals (volunteers) introduce students to a wide range of topics, including journalism, medicine, law, philosophy, the arts, astronomy and entrepreneurship. The goals of the program are to…

Ms. Sascha Bezemer is joining the team as our new intern. She is a biology master student with specialisation in health and disease. She is enrolled at Wageningen University and Research and will be working with us for 6 months.

Robert Sauerwein, CSO of TropIQ, receives a royal decoration for his pioneering work in malaria vaccinology and drug discovery. He receives the distinction of Knight in the Order of the Lion of the Netherlands.

Dr. van Nuland is an experienced biochemist with a PhD from Wageningen University in the Netherlands. He is an expert in industrial biotechnology and previously worked on metabolic engineering of microorganisms at the interface of public-private research.